Alvotech (ALVO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.55
+7.42%
Mkt Cap $1.05B
Next Earnings
In 8 daysWed, May 6, 2026
EPS Estimate
-$0.01
1 analysts
Revenue Estimate
$126.64M
Last quarter: missed by -6334.78% on EPS, +6.79% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.05B
P/E
1269.23
Fwd P/E
106.91
P/S
1.80
Rev TTM
—
EPS TTM
$0.00